跳至主要内容
临床试验/NCT05556967
NCT05556967已完成3 期

Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM in Normal Humans

University of Mississippi Medical Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年8月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Sulfoquinovose (SQ), ug/mL

研究概览

简要总结

This is a pilot study for identifying plasma and/or urine-derived adherence/surrogate biomarker candidates for verifying Immulina™ ingestion by human volunteers (collected before and after consumption of Immulina™, a natural dietary supplement).

详细描述

This pilot study is interventional, and all participants will receive one 800 mg dose of Immulina™ (four 200 mg capsules), a natural supplement, after a baseline blood and urine collection, then follow with 1 hour, 3 hour and 6 hour post-Immulina™ blood and urine collections. Samples will be sent to UM National Center for Natural Products Research (NCNPR) to analyze and compare timed blood and urine samples using gas chromatography and liquid chromatography to detect volatile and non-volatile compounds, gamma-linolenic acid (GLA), sulfoquinovose (SQ), 5'-methylsulfinyladenosine (MSA), palmitic acid, linoleic acid, palmitoleic acid and oleic acid to screen the chemical fingerprints of the human samples. The mean of the 7 biomarkers for the 4 time points will be measured and compared.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Males and females, 18-50 years old
  • •If female of childbearing potential, using acceptable means of birth control or postmenopausal for at least two years

排除标准

  • •pregnant or lactating females
  • •significant acute disease
  • •recurrent medications for chronic disease

研究组 & 干预措施

Immulina Dietary Supplementation

Experimental

Immulina Dietary Supplementation (200 mg per capsule) 4-200 mg capsules given by mouth once on the only study visit day.

干预措施: Immulina (Drug)

结局指标

主要结局

Sulfoquinovose (SQ), ug/mL

时间窗: Over 7 hour period

Differences in SQ between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

palmitic acid, ug/mL

时间窗: Over 7 hour period

Differences in palmitic acid between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

palmitoleic acid, ug/mL

时间窗: Over 7 hour period

Differences in palmitoleic acid between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

steric acid, ug/mL

时间窗: Over 7 hour period

Differences in steric acid between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

gamma-linolenic acid (GLA), ug/mL

时间窗: Over 7 hour period

Differences in GLA between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

5'-methylsulfinyladenosine (MSA), ug/mL

时间窗: Over 7 hour period

Differences in MSA between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

linoleic acid, ug/mL

时间窗: Over 7 hour period

Differences in linoleic acid between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

oleic acid, ug/mL

时间窗: Over 7 hour period

Differences in oleic acid between baseline, 1 hour post-Immulina, 3 hour post-Immulina and 6 hour post-Immulina

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验